Genetic association between serum 25-hydroxyvitamin D levels and functional outcome after ischemic stroke

被引:0
|
作者
Wu, Yudan [1 ]
Jin, Tianyu [2 ]
Pang, Qiongyi [2 ]
Cheng, Yifan [3 ]
机构
[1] Ningbo No 6 Hosp, Dept Rehabil, Ningbo, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Affiliated Hosp 2, Yuying Childrens Hosp, Dept Rehabil Med, Wenzhou, Zhejiang, Peoples R China
[3] Zhejiang Prov Peoples Hosp, Affiliated Peoples Hosp, Hangzhou Med Coll, Ctr Rehabil Med,Dept Neurol, Hangzhou, Zhejiang, Peoples R China
关键词
25-hydroxyvitamin D; Functional outcome of stroke; Prevalence; Mendelian randomization; MENDELIAN RANDOMIZATION; VITAMIN-D; INSTRUMENTS; RISK; BIAS;
D O I
10.1186/s12883-024-03972-x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BackgroundPrevious observational studies suggest that serum 25-hydroxyvitamin D [25(OH)D] levels may associate with functional outcome after ischemic stroke. However, the causal relationship is not yet defined. Consequently, this study employed two-sample Mendelian Randomization (MR) to elucidate the causal association between serum 25(OH)D levels and functional outcome after ischemic stroke.MethodsThe genome-wide association study (GWAS) for serum 25(OH)D levels included 417,580 patients of European descent. The GWAS for functional outcome after ischemic stroke is from Genetics of Ischemic Stroke Functional Outcome meta-analysis. Post-stroke outcomes were evaluated using two sets of binary categorical variables (0-2 vs. 3-6 and 0-1 vs. 2-6), and also as ordered modified Rankin Scale (mRS) variables at 3 months. Two-sample MR was used to assess whether the exposure causally affects the outcome. Inverse Variance Weighted (IVW) was the primary method for our MR analysis, which was further supported by sensitivity analyses to ensure the robustness of the results.ResultsThe primary analysis using IVW method indicated no significant casual association between serum 25(OH)D levels and mRS (0-1) vs. mRS (2-6) at 3 months (OR = 0.914, 95% CI: 0.587-1.422, P = 0.69), mRS (0-2) vs. mRS (3-6) at 3 months (OR = 0.699, 95% CI: 0.477-1.025, P = 0.07), and mRS at 3 months (OR = 1.202, 95% CI: 0.875-1.650, P = 0.26). Additionally, after adjusting for stroke severity, the IVW analysis also showed no significant association between serum 25(OH)D levels and mRS (0-1) vs. mRS (2-6) at 3 months (OR = 0.93, 95% CI: 0.55-1.56, P = 0.78), mRS (0-2) vs. mRS (3-6) at 3 months (OR = 0.73, 95% CI: 0.47-1.13, P = 0.16), and mRS at 3 months (OR = 1.09, 95% CI: 0.77-1.54, P = 0.62). The results of the sensitivity analysis suggest that our findings are robust.ConclusionOur MR study offers no genetic evidence supporting the effects of serum 25(OH)D levels on functional outcomes after ischemic stroke. The associations observed in previous observational studies may be attributed to residual confounding factors and reverse causality.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] An analysis of the association between the vitamin D pathway and serum 25-hydroxyvitamin D levels in a healthy Chinese population
    Zhang, Zeng
    He, Jin-Wei
    Fu, Wen-Zhen
    Zhang, Chang-Qing
    Zhang, Zhen-Lin
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28 (08) : 1784 - 1792
  • [22] Decreasing serum 25-hydroxyvitamin D levels and risk of early neurological deterioration in patients with ischemic stroke
    Hui, Wei
    Liu, Dezhi
    Li, Qin
    Wang, Li
    Tang, Qiqiang
    Wang, Guoping
    BRAIN AND BEHAVIOR, 2019, 9 (03):
  • [23] Serum 25-Hydroxyvitamin D Deficiency in Ischemic Stroke and Subtypes in Indian Patients
    Chaudhuri, Jaydip Ray
    Mridula, K. Rukmini
    Alladi, Suvarna
    Anamika, A.
    Umamahesh, M.
    Balaraju, Banda
    Swath, A.
    Bandaru, V. C. S. Srinivasarao
    JOURNAL OF STROKE, 2014, 16 (01) : 44 - 50
  • [24] Association between serum 25-hydroxyvitamin D levels and carotid atherosclerosis in chronic kidney disease patients
    Ng, Yong-Muh
    Lim, Soo-Kun
    Kang, Pei-San
    Kadir, Khairul Azmi Abdul
    Tai, Mei-Ling Sharon
    BMC NEPHROLOGY, 2016, 17
  • [25] The association between serum 25-hydroxyvitamin D levels and erectile dysfunction: a two-sample Mendelian randomization analysis
    Gao, Dawei
    Chen, Cheng
    Wu, Ziliang
    Li, Huakang
    Xie, Cheng
    Tang, Bo
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2024, 36 (08) : 879 - 885
  • [26] Discrepant association of serum C-3 epimer of 25-hydroxyvitamin D versus non-epimeric 25-hydroxyvitamin D with serum lipid levels
    Chailurkit, La-or
    Aekplakorn, Wichai
    Srijaruskul, Kriangsuk
    Ongphiphadhanakul, Boonsong
    LIPIDS IN HEALTH AND DISEASE, 2016, 15
  • [27] Lack of association between serum 25-hydroxyvitamin D levels and cervical human papillomavirus infection in systemic lupus erythematosus
    Garcia-Carrasco, M.
    Mendoza-Pinto, C.
    Munguia-Realpozo, P.
    Rodriguez-Gallegos, A.
    Vallejo-Ruiz, V.
    Munoz-Guarneros, M.
    Mendez-Martinez, S.
    Soto-Santillan, P.
    Pezzat-Said, E.
    Reyes-Leyva, J.
    Lopez-Colombo, A.
    Ruiz-Argueelles, A.
    Cervera, R.
    LUPUS, 2015, 24 (06) : 606 - 612
  • [28] Effects of 25-Hydroxyvitamin D Levels on Renal Function: A Bidirectional Mendelian Randomization Study
    Adi, Manel
    Ghanbari, Faegheh
    Downie, Mallory L.
    Hung, Adriana
    Robinson-Cohen, Cassiane
    Manousaki, Despoina
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (06) : 1442 - 1451
  • [29] Evaluation of 25-Hydroxyvitamin D Serum Levels in Patients With Fibromyalgia
    Pena, Caris de Rezende
    Grillo, Luciane Peter
    das Chagas Medeiros, Marta Maria
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (08) : 365 - 369
  • [30] Serum 25-Hydroxyvitamin D Levels in Patients with Vulvar Cancer
    Salehin, Darius
    Haugk, Christina
    Thill, Marc
    Cordes, Tim
    Hornung, Daniela
    Abu-Hechle, Andre
    Hemmerlein, Bernhard
    Friedrich, Michael
    ANTICANCER RESEARCH, 2012, 32 (01) : 265 - 270